(Q44429302)

2 December 2017

0 references

1 reference

title

Androgens and women at the menopause and beyond (English)

1 reference

2 December 2017

Androgens and Women at the Menopause and Beyond (English)

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

30 December 2023

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

30 December 2023

author name string

John E. Morley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730248

30 December 2023

H. Mitchell Perry

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730248

30 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

published in

The Journals of Gerontology

1 reference

2 December 2017

58

1 reference

2 December 2017

5

1 reference

2 December 2017

M409-16

1 reference

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

2 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Androgen deficiency in aging men: role of testosterone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

A critical evaluation of simple methods for the estimation of free testosterone in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

The therapeutic use of androgens in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

The postmenopausal ovary is not a major androgen-producing gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Hysterectomy, Oophorectomy, and Endogenous Sex Hormone Levels in Older Women: The Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Transdermal testosterone treatment in women with impaired sexual function after oophorectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Anorexia, sarcopenia, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Predictors of skeletal muscle mass in elderly men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Frailty in older adults: evidence for a phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Testosterone improves rehabilitation outcomes in ill older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Pharmacokinetic overview of Ortho Evra/Evra

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Dehydroepiandrosterone status in postmenopausal women is determined by the gene for the vitamin D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Uses of DHEA in aging and other disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

The direct proliferative stimulus of dehydroepiandrosterone on MCF7 breast cancer cells is potentiated by overexpression of aromatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Biological Actions of Androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Androgen receptor status in female breast cancer: RT-PCR and Western blot studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

17alpha-methyl testosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Anorexia in older persons: epidemiology and optimal treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

The effects of tibolone on mood and libido.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Assessment of the effectiveness of postmenopausal tibolone therapy on neural functions by measuring visual evoked potentials: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Cognitive effects of 10 years of hormone-replacement therapy with tibolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Psychological effects of hormone replacement therapy: a comparison of tibolone and a sequential estrogen therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Muscle strength and tibolone: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

The effect of tibolone on the lipoprotein profile of postmenopausal women with type III hyperlipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Effects of tibolone on thromboxane B(2) levels in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

A randomised placebo controlled trial of the effects of tibolone on blood pressure and lipids in hypertensive women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F58.5.M409

The endocrine transition around menopause--a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women

21 January 2018

14

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Ovarian and Adrenal Contribution to Peripheral Androgens During the Menstrual Cycle

30 December 2023

21

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Journal of Psychosomatic Obstetrics & Gynecology

30 December 2023

25

15

56

1994

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Androgens and the menopause; a study of 40-60-year-old women

30 December 2023

26

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study

30 December 2023

28

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

30 December 2023

Sarcopenia

47

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Testosterone and leptin in older African-American men: relationship to age, strength, function, and season

30 December 2023

54

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Comparison of the biochemical effects of testosterone and estrogen on bone markers in surgically menopausal women

30 December 2023

57

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Total and free estrogens and androgens in postmenopausal women with hip fractures

30 December 2023

58

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens

30 December 2023

59

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women

30 December 2023

60

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

30 December 2023

83

14

2113

Secreto

1994

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer

30 December 2023

87

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Administration of testosterone undecanoate in postmenopausal women: effects on androgens, estradiol, and gonadotrophins

30 December 2023

90

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone

30 December 2023

91

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

30 December 2023

92

15

212

Gooren

1994

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis

30 December 2023

93

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Long term effects of tibolone on the genital tract in postmenopausal women.

30 December 2023

102

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study

30 December 2023

119

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone

30 December 2023

121

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

European Journal of Gynaecological Oncology

30 December 2023

123

23

127

Lippert

2002

1 reference

https://api.crossref.org/works/10.1093/GERONA/58.5.M409

30 December 2023

Identifiers

1 reference

release_xcx72ftptvhcjbvewoi5zq6lia

2 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xcx72ftptvhcjbvewoi5zq6lia

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference